Abstract
Arbutamine, a synthetic catecholamine, coupled with a closed-loop, computerized delivery system was evaluated in conjunction with technetium-99m sestamibi scintigraphy and echocardiography for the detection of coronary artery disease. Concordance between the imaging methods was 68%, with a similar sensitivity for coronary disease using echocardiography (78%) and technetium-99m sestamibi (76%), although more arbutamine-induced ischemia was noted with perfusion imaging.
References
Mar 1, 1992·Circulation·M A QuiñonesW A Zoghbi
Nov 15, 1991·Journal of the American College of Cardiology·D J PennellP J Ell
Nov 1, 1995·Journal of the American College of Cardiology·C A DennisM R Starling
Nov 1, 1995·Journal of the American College of Cardiology·H KiatD S Berman
Nov 1, 1995·Journal of the American College of Cardiology·J L CohenW F Armstrong
Dec 1, 1994·European Journal of Nuclear Medicine·L BajnokT Fülöp
Jan 15, 1994·The American Journal of Cardiology·S D HermanG V Heller
Sep 1, 1994·Circulation·B D BeleslinZ Vasiljevic-Pokrajcic
Feb 1, 1994·Journal of the American College of Cardiology·M D CerqueiraA S Iskandrian
Feb 1, 1993·Circulation·T MarwickJ Melin
Jun 1, 1993·Journal of the American College of Cardiology·J T HaysM S Verani
Jun 1, 1993·Journal of the American College of Cardiology·T ForsterP M Fioretti
Jul 1, 1993·Journal of the American College of Cardiology·T MarwickJ Melin
Jan 1, 1994·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·A S IskandrianJ Heo
Jul 1, 1994·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·M S Verani
Jan 1, 1995·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·J LetteS Nattel